Trial intelligence / Profile preview

Celecoxib for inflammation in hypertension and CAD

NCT00471341Phase 4Completed

Sponsor
University of Florida
Start
Jul 2002
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of celecoxib in coronary artery disease (CAD), hypertension (HTN), sponsored by University of Florida. Started Jul 2002; status: completed.

02

Drugs

celecoxib
03

Conditions

coronary artery disease (CAD)hypertension (HTN)

Beyond the preview

Go deeper on NCT00471341.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00471341.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call